País: Regne Unit
Idioma: anglès
Font: MHRA (Medicines & Healthcare Products Regulatory Agency)
Simvastatin
Rosemont Pharmaceuticals Ltd
C10AA01
Simvastatin
8mg/1ml
Oral suspension
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02120000; GTIN: 5016119205897
0 10 20 30 40 50 60 70 80 90 100 JOB INFORMATION Product Name: Strength: Keyline Ref: Font Type: Font Size: Pharmacode: Dimensions: EAN Code: Folded Size: No. of Colours: Tabbed: Pack Size: Bottle Size: Design Icon: Print Colours: Non-print Colours: New Item Code: Previous Item Code: Supplier Code: Page Number: COLOURS ARTWORK VERSION: Date: Date: Operator: Operator: PREFLIGHT VERSION: JOB SPECIFICATION MAIN BODY TEXT Univers Roman UNIVERS BOLD 40mg/5ml BLACK 7474 PANTONE PANTONE 265 CUTTER BRAILLE UKL412 402 210 x 300mm N/A 30 x 150mm 1 7pt No 150ml 150ml N/A F6FD1RBJ3 F6FD1RBJ2 N/A 1 of 2 Simvastatin Rosemont 40mg/5ml Oral Suspension (UK & IRL) 14/02/18 - DH - 1 - APPROVALS THIRD PARTY APPROVAL REQUIRED Name: Name: Signature: Signature: Date: Date: AUTHORITY APPROVAL SUPPLIED REGULATORY SIGN-OFF YES YES NO N/A TICK APPLICABLE BOX TICK APPLICABLE BOX READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. n Keep this leaflet. You may need to read it again. n If you have any further questions, ask your doctor or pharmacist. n This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. n If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Simvastatin Rosemont is and what it is used for 2. What you need to know before you take Simvastatin Rosemont 3. How to take Simvastatin Rosemont 4. Possible side effects 5. How to store Simvastatin Rosemont 6. Contents of the pack and other information 1. WHAT SIMVASTATIN ROSEMONT IS AND WHAT IT IS USED FOR The name of your medicine is Simvastatin Rosemont 40mg/5ml Oral Suspension (called simvastatin in this leaflet). This belongs to a group of medicines called HMG-CoA reductase inhibitors (also known as statins). This medicine works by lowering the amount of cholesterol and fatty substances called Llegiu el document complet
OBJECT 1 SIMVASTATIN ROSEMONT 40MG/5ML ORAL SUSPENSION Summary of Product Characteristics Updated 26-Mar-2018 | Rosemont Pharmaceuticals Limited 1. Name of the medicinal product Simvastatin Rosemont 40mg/5ml Oral Suspension Simvastatin 2. Qualitative and quantitative composition One ml contains 8mg simvastatin (40mg/5ml) Excipients with known effect: 1ml contains methyl parahydroxybenzoate (E218) 1.8mg, ethyl parahydroxybenzoate (E214) 0.4mg, and propyl parahydroxybenzoate (E216) 0.16mg. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Oral Suspension A white to off-white suspension with lime flavour and odour. 4. Clinical particulars 4.1 Therapeutic indications Hypercholesterolaemia Treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. Treatment of homozygous familial hypercholesterolaemia (HoFH) as an adjunct to diet and other lipid- lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate. Cardiovascular prevention Reduction of cardiovascular mortality and morbidity in patients with manifest atherosclerotic cardiovascular disease or diabetes mellitus, with either normal or increased cholesterol levels, as an adjunct to correction of other risk factors and other cardioprotective therapy (see section 5.1). 4.2 Posology and method of administration Posology The dosage range is 5 - 80mg/day (0.625 – 10ml) given orally as a single dose in the evening. Adjustments of dosage, if required, should be made at intervals of not less than 4 weeks, to a maximum of 80mg/day (10ml) given as a single dose in the evening. The 80mg (10ml) dose is only recommended in patients with severe hypercholesterolaemia and at high risk for cardiovascular complications who have not achieved their treatment goals on lower doses and when the benefits are expected to outweigh the potential risks (see sections 4.4 and 5.1). This product should not Llegiu el document complet